Effectiveness and safety of a product containing diosmin, coumarin, and arbutin (Linfadren®) in addition to complex decongestive therapy on management of breast cancer-related lymphedema.
Angelo CacchioRosa PrencipeMarina BertoneLuciana De BenedictisLuciano TaglieriErika D'EliaCesidia CentolettiGiancarlo Di CarloPublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2018)
Linfadren® in addition to CDT was a safe and effective therapy for reducing BCRL and was better than CDT alone.
Keyphrases